300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Oman
Cameroon
Colombia
New Zealand
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Moldova
Malawi
Seychelles
United Kingdom
Botswana
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Ireland (July 2026)

The most active venture capital funds investing in Ireland Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Ireland Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Enterprise Ireland
VC Fund
30 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $494k–$12M
SOSV
VC Fund
19 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Western Development Commission
VC Fund
13 Ireland, United States Seed, Series A Health Care, Medical Device, Biotechnology $642k–$11M
Irrus Investments
VC Fund
7 Ireland, Sweden, United States Seed, Series A Health Care, Medical Device, Biotechnology $713k–$8.8M
Kernel Capital
VC Fund
7 Ireland, United Kingdom, France Seed, Series A Software, Information Technology, Health Care $531k–$9M
Fountain Healthcare Partners
VC Fund
6 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $3.3M–$110M
Seroba Life Sciences
VC Fund
6 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
AIB Seed Capital Fund
VC Fund
5 Ireland, United States, Jersey Seed, Series A Software, Health Care, Medical $549k–$8.1M
Atlantic Bridge
VC Fund
5 United States, Ireland, United Kingdom Series A, Series B Software, Information Technology, Artificial Intelligence $4.5M–$62M
HBAN
VC Fund
4 Ireland, United Kingdom, United States Seed, Series A Health Care, Software, Medical Device $604k–$8.8M
European Investment Bank
VC Fund
4 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$658M
HBAN Medtech Syndicate
VC Fund
3 Ireland Seed, Series B Medical Device, Medical, Health Care $1.3M–$11M
Atlantic Bridge University Fund
VC Fund
3 Ireland, United States Seed, Series A, Series B Medical Device, Health Care, Big Data $823k–$80M
Boole Investment Syndicate
VC Fund
3 Ireland, Estonia, United States Seed, Series A SaaS, Software, Biotechnology $642k–$2.2M
Act Venture Capital
VC Fund
3 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Artificial Intelligence $823k–$13M
The Yield Lab Europe
VC Fund
3 Ireland, France, United Kingdom Seed, Series A AgTech, Agriculture, Biotechnology $955k–$10M
Elkstone Capital Partners
VC Fund
2 Ireland, United Kingdom, United States Seed, Series A Software, Artificial Intelligence, Health Care $610k–$20M
LSP Dementia Fund
VC Fund
2 Belgium, Ireland, The Netherlands Series A, Post-IPO Equity Biotechnology, Life Science, Pharmaceutical $39M–$39M
Furthr VC
VC Fund
2 Ireland Seed, Pre-Seed Medical Device, Medical, Software $878k–$6.3M
SVG Ventures
VC Fund
2 United States, Canada, Ireland Pre-Seed, Seed AgTech, Agriculture, Farming
HealthCap
VC Fund
2 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$92M
Enterprise Equity
VC Fund
2 Ireland, United States, United Kingdom Seed, Series B Software, Information Technology, Health Care $549k–$7.5M
Lightstone Ventures
VC Fund
2 United States, Ireland, Singapore Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7M–$105M
Infinity Capital
VC Fund
2 United States, Ireland, Canada Series B, Series D Semiconductor, E-Commerce, Electronics
ARCH Venture Partners
VC Fund
2 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $8.4M–$250M
Ascentifi
VC Fund
2 Ireland Seed, Series A, Venture - Series Unknown Health Care, Medical Device, Medical $2.3M–$11M
The Nest Family Office
VC Fund
1 United States, United Kingdom Series A Farming, Finance, Analytics
Lingotto
VC Fund
1 United States, United Kingdom, India Series B, Series A Artificial Intelligence, Machine Learning, Energy
Development Capital
VC Fund
1 Ireland, United States, United Kingdom Seed, Private Equity Manufacturing, Telecommunications, VoIP
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical
The First Thirty
VC Fund
1 Sweden Seed B2B, SaaS, Big Data
Third Swedish National Pension Fund
VC Fund
1 Sweden, Denmark, Ireland Post-IPO Equity Biotechnology, Manufacturing, Pharmaceutical $46M–$85M
Ireland Strategic Investment Fund
VC Fund
1 Ireland, United States, Israel Series C, Series D Software, Analytics, Biotechnology
WxNW
VC Fund
1 Ireland Seed Sales, Consumer, Marketing
The Yield Lab
VC Fund
1 United States, Argentina, Brazil Seed, Series A, Convertible Note Agriculture, Biotechnology, AgTech
Moffett Investment Holdings
VC Fund
1 Ireland Series A, Series B Medical, Health Care, Biotechnology
Clay Capital
VC Fund
1 France, Israel, Germany Series A, Series B Food and Beverage, Biotechnology, Health Care
Johnson & Johnson Innovation
VC Fund
1 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Medical
Kreos Capital
VC Fund
1 United Kingdom, Germany, United States Debt Financing, Series B, Post-IPO Debt Biotechnology, Health Care, Software
Claret Capital Partners
VC Fund
1 United Kingdom, Germany, United States Debt Financing, Series A Software, Information Technology, Mobile
Polaris Partners
VC Fund
1 United States, Ireland, Singapore Series B, Series A, Series C Health Care, Biotechnology, Medical
Apicap
VC Fund
1 France, United States, Turkey Series A, Series B Software, Information Technology, Mobile
Bpifrance
VC Fund
1 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care
Spark Crowdfunding
VC Fund
1 Ireland Seed, Equity Crowdfunding CRM, Software, Transportation
Sol Global investments
VC Fund
1 United States, Canada, Ireland Corporate Round, Series A, Series B Health Care, Cannabis, Cloud Computing
Medicxi
VC Fund
1 United States, United Kingdom, The Netherlands Series A, Series B, Seed Biotechnology, Health Care, Pharmaceutical
Inventages Venture Capital Investment Inc.
VC Fund
1 United States, United Kingdom, Canada Series A, Series B Biotechnology, Health Care, Therapeutics
MML Capital Partners
VC Fund
1 United Kingdom, France, United States Private Equity, Series A Manufacturing, Packaging Services, Information Technology
DeepIE Ventures Management Co.
VC Fund
1 Ireland Seed AgTech, Agriculture, Machinery Manufacturing
Google Ventures
VC Fund
1 United States, United Kingdom, Switzerland Series A, Series B, Seed Software, Health Care, Biotechnology
Access all 230 VC funds in Ireland Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 30 investments in Ireland Biotech startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 633
  • Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • Revive Active — Revive Active health supplement is the only brand that unlocks your abundant natural energy to maximize the lifestyle you want because it’s a supplement that does not compromise on amount or quality but is abundant with fantastic ingredients. Revive Active Health Supplement is a high quality blend of 26 ingredients delivered in one convenientsachet. The unique blend of vitamins and minerals combine to provide a multitude of health benefits including natural sustained energy without the use of sugar and caffeine. The revolutionary product also brings two key Nobel prize-winning ingredients together for the first time. The combined inclusion of Coenzyme Q10 and L-Arginine further improves Revive Active’s ability to enhance energy and vitality and support a healthy immune system in regular consumers all for as little as a cup of coffee per day.Unlike traditional fish oil supplements, Revive Krill Oil is an extremely bioavailable source of EPA and DHA. Key to the enhanced absorption is the unique structure of the omega-3s. Fish oil omega-3s are found in a triglyceride form, which repel water impairing absorption in the digestive tract. Krill oil is found in a phospholipid form which attracts water promoting fast and efficient absorption. This helps deliver the essential omega-3s to the places you need it most.
  • Code Institute — Join our accredited online programs in AI, Data Science, & Full Stack Development. 98% of grads employed in 12 months. Learn from experts & get hired by top tech companies.
  • Irish Bioeconomy Foundation — The Irish Bioeconomy Foundation was founded to establish a fora of industry, academia & policy leaders around Ireland's emerging bioeconomy
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 19 investments in Ireland Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 13 investments in Ireland Biotech startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Ireland, United States

Investor stats

  • Total investments: 44
  • Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Show all investments...

Irrus Investments
VC Fund · Limerick, Limerick, Ireland · 7 investments in Ireland Biotech startups

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Ireland, Sweden, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $713k–$4.7M; Series A $2.2M–$8.8M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
  • Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
  • Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
Show all investments...

Kernel Capital
VC Fund · Cork, Cork, Ireland · 7 investments in Ireland Biotech startups

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, France

Investor stats

  • Total investments: 92
  • Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2013

Portfolio highlights

  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotech startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 50
  • Round size: Series A $6.6M–$43M; Series B $5.5M–$68M; Series C $3.3M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $128M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
  • Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company isbased in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education.
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotech startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $111M in 2017

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Show all investments...

AIB Seed Capital Fund
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Biotech startups

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States, Jersey

Investor stats

  • Total investments: 49
  • Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Atlantic Bridge
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Biotech startups

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 144
  • Round size: Series A $4.5M–$26M; Series B $10M–$62M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Aizon — Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.
  • Aiqudo — Aiqudo offers an artificial intelligence-based technology that connects voice computing to the mobile app ecosystem. Its Voice-to-Action platform lets people use natural voice commands to instantly execute actions in their mobile apps. The company was founded in 2017 and is headquartered in Campbell, California.
  • Luminate Medical — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

HBAN
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Biotech startups

HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 66
  • Round size: Seed $604k–$3.5M; Series A $1.2M–$8.8M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
  • Glitch Ads — Launch AI Powered Google Ad Campaigns in Minutes. Think of us like an agency in a box. Built for speed. Priced for scaling companies. Powered by AI.
  • Change by Degrees — Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 4 investments in Ireland Biotech startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 489
  • Round size: Post-IPO Debt $16M–$658M; Debt Financing $16M–$370M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Affibody — Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a largenumber of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
  • RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Show all investments...

HBAN Medtech Syndicate
VC Fund · 3 investments in Ireland Biotech startups

HBAN Medtech Syndicate

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 13
  • Round size: Seed $1.3M–$11M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Show all investments...

Atlantic Bridge University Fund
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

We invest in entrepreneurs with the ambition to create world-class companies of scale.

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Big Data
  • Stage:Seed, Series A, Series B
  • Geography: Ireland, United States

Investor stats

  • Total investments: 31
  • Round size: Seed $823k–$3.8M; Series A $3.1M–$12M; Series B $16M–$80M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • AYLIEN — Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs.
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Show all investments...

Boole Investment Syndicate
VC Fund · Cork, Cork, Ireland · 3 investments in Ireland Biotech startups

Boole Investment Syndicate invests in new technology start-up's with scalability.

Show more...

Investment focus

  • Industry: SaaS, Software, Biotechnology
  • Stage:Seed, Series A
  • Geography: Ireland, Estonia, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $642k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch
Show all investments...

Act Venture Capital
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 159
  • Round size: Seed $823k–$5M; Series A $2.3M–$13M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $164M in 2022

Portfolio highlights

  • Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.
  • SiriusXT — SiriusXT is transforming cell and tissue imaging with the SXT-100, the first commercial, laboratory scale soft x-ray microscope.
  • Fresco — Unlock the value of your kitchen appliances, get to market fast, and build a community of happy home cooks.
Show all investments...

The Yield Lab Europe
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Biotechnology
  • Stage:Seed, Series A
  • Geography: Ireland, France, United Kingdom

Investor stats

  • Total investments: 38
  • Round size: Seed $955k–$2.9M; Series A $2.1M–$10M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $52M in 2021

Portfolio highlights

  • BBLeap — BBLeap is a company that operates in the manufacturing industry, specifically focusing on the agricultural sector. The company's main offering is the LeapBox system, a modular solution that can be attached to any new or used sprayer. This system is designed to enhance the efficiency and effectiveness of crop spraying, addressing the issue ofover-application and weak spots in fields. BBLeap's approach, termed 'Farming On Plant Level', aims to consider individual plant needs and environmental factors such as soil conditions and weather. The company's vision is to provide better spraying equipment to the agricultural sector, contributing to more sustainable and precise farming practices.
  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Show all investments...

Elkstone Capital Partners
VC Fund · Dublin, Dublin, Ireland · 2 investments in Ireland Biotech startups

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 90
  • Round size: Seed $610k–$6.3M; Series A $5.1M–$20M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $110M in 2023

Portfolio highlights

  • Danalto — Simple, cost-effective, high-accuracy Location Services for large open environments, both indoor and outdoor. Asset Tracking made simple!
  • MEG — MEG is a powerful end-to-end Quality Management System for healthcare. Manage quality, patient safety, compliance and accreditation processes all from one place.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

LSP Dementia Fund
VC Fund · 2 investments in Ireland Biotech startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Pharmaceutical
  • Stage:Series A, Post-IPO Equity
  • Geography: Belgium, Ireland, The Netherlands

Investor stats

  • Total investments: 5
  • Round size: Series A $39M–$39M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Nobi — Fall detection for the elderly at your home or in a residential care center with the smart Nobi lamp. Nobi ensures that you can be helped quickly.
  • Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
  • QurAlis — QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
Show all investments...

Furthr VC
VC Fund · Dublin, Dublin, Ireland · 2 investments in Ireland Biotech startups

We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Software
  • Stage:Seed, Pre-Seed
  • Geography: Ireland

Investor stats

  • Total investments: 28
  • Round size: Seed $878k–$6.3M; Pre-Seed $878k–$2.2M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2019

Portfolio highlights

  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • MEG — MEG is a powerful end-to-end Quality Management System for healthcare. Manage quality, patient safety, compliance and accreditation processes all from one place.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

SVG Ventures
VC Fund · Los Gatos, California, United States · 2 investments in Ireland Biotech startups

We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Farming
  • Stage:Pre-Seed, Seed
  • Geography: United States, Canada, Ireland

Investor stats

  • Total investments: 86
  • Lead/follow: no public data

Portfolio highlights

  • FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
  • Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
  • Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Ireland Biotech startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 130
  • Round size: Series A $5.7M–$85M; Series B $12M–$92M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Enterprise Equity
VC Fund · Dundalk, Louth, Ireland · 2 investments in Ireland Biotech startups

Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotech startups, 7 in the past 12 months

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 84
  • Round size: Series A $7M–$102M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Psivant Therapeutics — Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
  • Crystalys Therapeutics — Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Show all investments...

Infinity Capital
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotech startups

Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.

Show more...

Investment focus

  • Industry: Semiconductor, E-Commerce, Electronics
  • Stage:Series B, Series D
  • Geography: United States, Ireland, Canada

Investor stats

  • Total investments: 33
  • Lead/follow: no public data

Portfolio highlights

  • AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
  • BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
  • Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 2 investments in Ireland Biotech startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 414
  • Round size: Series A $8.4M–$213M; Series B $14M–$250M; Series C $15M–$175M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Synchron — The endovascular brain computer interface.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • HI-Bio — HI-Bio leverages human genetic and immunological insights to deliver targeted, effective medicines to patients with immune-mediated diseases.
Show all investments...

Ascentifi
VC Fund · Galway, Galway, Ireland · 2 investments in Ireland Biotech startups

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 8
  • Round size: Seed $2.3M–$11M; Venture - Series Unknown $3M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Show all investments...

The Nest Family Office
VC Fund · Berchem, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Ireland Biotech startups

Investment Management. Driving impact through investments in purpose-driven companies.

Show more...

Investment focus

  • Industry: Farming, Finance, Analytics
  • Stage:Series A
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Edacious — Edacious is a new food system. Our company can help you differentiate the quality of your food.
  • Antler Bio — Antler Bio uses gene expression data for herd management and offers genomic data analysis services.
  • Agricarbon — Soil carbon measurement that is rigorous, cost-effective, and trusted by multinational project developers and companies.
Show all investments...

Lingotto
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Lingotto is an investment management company owned by Exor, one of Europe's largest diversified holding companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Machine Learning, Energy
  • Stage:Series B, Series A
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
  • Viewture — Viewture uses statistics and analytics to help content creators find new ways to fund their work. Viewture was founded by David Page.
  • Airwallex — Grow your business faster with Airwallex - global business accounts, high speed transfers, multi-currency cards, online payments, embedded finance, and more.
Show all investments...

Development Capital
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotech startups

At Development Capital, they are aware of the significant growth opportunities available to mid-sized companies and understand the management teams’ unique requirement for not only finance, but also for a funding partner who will bring experience, expertise and international reach to assist secure and maximise the business growth opportunity.Development Capital provides investee companies with a unique and unprecedented partnership approach which will maximise the growth opportunity in the most prompt and efficient manner. In addition to their experienced Investment Directors, their partners include:High profile and experienced Industry Experts who will provide direction and support to investee companies; andMajor Irish Corporates who have committed not only funding but also their international experience.

Show more...

Investment focus

  • Industry: Manufacturing, Telecommunications, VoIP
  • Stage:Seed, Private Equity
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 14
  • Lead/follow: no public data

Portfolio highlights

  • IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
  • Nomadic Dairy — Nomadic Dairy is a growing, premium branded yogurt manufacturer. The company supplies multiple products across the UK and Republic of Ireland.
  • Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Ireland Biotech startups, 6 in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 152
  • Lead/follow: no public data

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
The First Thirty
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

NatureTech venture firm investing in disruptive technologies connecting human and planetary health. Impact target to enhance human health by regenerating more than 30m hectares.

Show more...

Investment focus

  • Industry: B2B, SaaS, Big Data
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Cerve — The Cerve platform establishes a personalised, 2-way and automated communication between wholesalers and B2B buyers online — delivering bespoke and dynamic product catalogues, pricing, delivery terms and deals to each and every buyer on any platform and device.As an end-to-end platform, Cerve provides wholesalers with a full set of productsincluding an AI infrastructure, an ordering platform, a sales app and a wholesaler platform.
  • Edacious — Edacious is a new food system. Our company can help you differentiate the quality of your food.
  • Antler Bio — Antler Bio uses gene expression data for herd management and offers genomic data analysis services.
Show all investments...

Third Swedish National Pension Fund
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Ireland Biotech startups

Third Swedish National Pension Fund employs different investment strategies in the interest of spreading risk and protecting pensions for current and future pensioners. The firm was founded in 2001 and is headquartered in Stockholm, Sweden.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Pharmaceutical
  • Stage:Post-IPO Equity
  • Geography: Sweden, Denmark, Ireland

Investor stats

  • Total investments: 5
  • Round size: Post-IPO Equity $46M–$85M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Northvolt — Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • ITAB Shop Concept — Co-creating retail experiences that connect people with the brands they love.
Show all investments...

Ireland Strategic Investment Fund
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotech startups

The Ireland Strategic Investment Fund, managed and controlled by the National Treasury Management Agency (NTMA), is an €8.5 billion sovereign development fund with a unique mandate. We have a statutory mandate to invest on a commercial basis in a manner designed to support economic activity and employment in Ireland. With €8.5 billion availableto deploy, the Fund differs from other pools of capital in a number of key respects. It has a long investment time horizon and therefore can act as a permanent or patient source of long-term capital. It has flexibility up and down the capital structure and can therefore meet changing capital needs and gaps in the marketplace.The Fund will seek to invest in transactions where it can make a difference, where its characteristics can enable commercial investment transactions with positive economic impact and can make it an attractive “investor of choice” for company and project sponsors and advisors.We are a strategic investor with strong connections in both the public and private sectors. We are uniquely positioned to make connections and drive innovation across multiple industry players developing and delivering innovative opportunities that might otherwise go unrealised.

Show more...

Investment focus

  • Industry: Software, Analytics, Biotechnology
  • Stage:Series C, Series D
  • Geography: Ireland, United States, Israel

Investor stats

  • Total investments: 29
  • Lead/follow: no public data

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Aer Lingus — Aer Lingus is a national airline. They focus on aer lingus, business class, and aerClub.
  • Vectra AI — Vectra is the world leader in AI threat detection and response. The Cognito platform uses AI to detect attackers in real time and perform conclusive investigations.
Show all investments...

WxNW
VC Fund · 1 investments in Ireland Biotech startups

WxNW operates as an investment firm.

Show more...

Investment focus

  • Industry: Sales, Consumer, Marketing
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • UrbanFox — Discover cutting-edge AI data processing solutions tailored to your needs. Elevate your business with innovative technology, personalized service, and a commitment to excellence.
Show all investments...

The Yield Lab
VC Fund · St Louis, Missouri, United States · 1 investments in Ireland Biotech startups

The Yield Lab invests in AgriFood Tech companies with technologies focused on crops, animal health, digital agriculture, logistics, and food ingredients. Initial investments range from $100,000 – $1.5M.

Show more...

Investment focus

  • Industry: Agriculture, Biotechnology, AgTech
  • Stage:Seed, Series A, Convertible Note
  • Geography: United States, Argentina, Brazil

Investor stats

  • Total investments: 61
  • Lead/follow: no public data

Portfolio highlights

  • Proba — Unlock the value of your climate actions with Proba. Transform your efforts into tradable carbon certificates, connect with partners, and create new revenue streams for your business. Schedule a call now.
  • Sundew — Targeting water-borne pests and diseases
  • Produzindo Certo — Produzindo Certo focuses on providing solutions in the farming industry. The company offers a digital platform that automates agricultural processes, aiming to enhance efficiency and sustainability. It engages in projects that promote responsible farming practices, including carbon management and sustainable soybean production. The companycollaborates with ranchers and other stakeholders to implement pilot projects that transform social and environmental practices in agriculture.
Show all investments...

Moffett Investment Holdings
VC Fund · Monaghan, Monaghan, Ireland · 1 investments in Ireland Biotech startups

Moffett Investment Holdings is an investment firm

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Show all investments...

Clay Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Ireland Biotech startups

VisVires New Protein is a pioneering investor focused on solving the persistent challenges of our food and feed system.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Israel, Germany

Investor stats

  • Total investments: 30
  • Lead/follow: no public data

Portfolio highlights

  • MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
  • Infinite Roots — Mushlabs is a biotech company using fermentation to create the next generation of sustainable foods from the roots of mushrooms.
  • Abolis Biotechnologies — Abolis is a biotech innovator providing sustainable, tailor-made solutions for food, health, cosmetics, and chemicals industries. Embrace biotechnology for a better future.
Show all investments...

Johnson & Johnson Innovation
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Ireland Biotech startups

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 113
  • Lead/follow: no public data

Portfolio highlights

  • G.I. Windows — G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology. This technology will allow less invasive surgery and offer the capability of developing more procedures new to the world. The company is creating a new category in healthcare designed to create less invasive surgery and reducehealthcare costs.G.I. Windows is committed to innovation that helps improve the way diagnostic and interventional procedures impact the essential balance between both patients and the healthcare system. It was founded in 2012 and is headquartered in West Bridgewater, Massachusetts, United States.
  • HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
  • Aro Biotherapeutics — Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
Show all investments...

Kreos Capital
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €150 million. Since 1998, as the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel: Kreos has completed nearly 450 transactions and committed €1.8 billion in 14 different countries. Kreos has aproven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors.The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.Kreos is a value added partner, able to offer additional capital and more flexibility with lower equity dilution. Kreos's international team has extensive entrepreneurial, debt financing and equity investing experience, covering all local European markets from its locations in London, Tel Aviv and Stockholm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Debt Financing, Series B, Post-IPO Debt
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 129
  • Lead/follow: no public data

Portfolio highlights

  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • BiolineRx — BioLineRx is building a best-in-class pipeline designed to deliver meaningful therapeutic benefit to patients with certain cancers and rare diseases.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Claret Capital Partners
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.

Show more...

Investment focus

  • Industry: Software, Information Technology, Mobile
  • Stage:Debt Financing, Series A
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 91
  • Lead/follow: no public data

Portfolio highlights

  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • Bitwala — Nuri empowers people to manage and grow their wealth through innovative technologies.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Polaris Partners
VC Fund · Boston, Massachusetts, United States · 1 investments in Ireland Biotech startups

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 440
  • Lead/follow: no public data

Portfolio highlights

  • Jnana Therapeutics — Jnana was founded by leading academic scientists, drug developers and investors to develop medicines that transform the lives of patients.
  • Phreesia — Phreesia is a privately held company focused on patient check-in. The company replaces the outdated patient clipboard in physician offices with a free wireless touch screen and swipe card enabled PhreesiaPad. Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad from the patient in a secure andHIPAA-compliant fashion. The product is designed to interface with physicians' existing and future technology and is compatible with electronic medical records (EMRs)Phreesia does not require any changes to the physician workflow and captures comprehensive patient information that can automatically be printed to reports for administrative and clinical staff. The company also improves the patient experience by better preparing them for their appointments, offering up-to-date health education relevant to their medical concerns, and enabling them to verify, rather than re-enter, information recorded at previous visits to the medical practice. The company draws on the expertise of a leading Medical Advisory Board and has initiated a series of patient care initiatives that concentrate on both wellness and disease prevention. The company is backed by premier venture capital firms and has received $13.25 million in financing to date.
  • Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
Show all investments...

Apicap
VC Fund · Paris, Ile-de-France, France · 1 investments in Ireland Biotech startups

Apicap offers investment and co-investment solutions for managers, wealthy private clients and institutional investors.

Show more...

Investment focus

  • Industry: Software, Information Technology, Mobile
  • Stage:Series A, Series B
  • Geography: France, United States, Turkey

Investor stats

  • Total investments: 45
  • Lead/follow: no public data

Portfolio highlights

  • Crowdaa — Create, customize, and launch your mobile app without writing a single line of code.
  • Feelbat — This is the homepage of the websiteMonitor your infrastructure in real-time with Feelbat. Our smart sensors provide precise data to anticipate risks and ensure structural safety.
  • Karma Koma — Karma Koma is specializes in retail and French and international distribution with multi-brand resellers.
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 1 investments in Ireland Biotech startups, 79 in the past 12 months

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 910
  • Lead/follow: no public data

Portfolio highlights

  • AUSTRAL Dx — AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs. The company was founded in 2021 and is based in Paris.
  • Aircap — Aircap revolutionizes investment with a banking platform dedicated to investors.
  • Electra — Electra is a platform that provides Charging stations Ultrafast for electric vehicles.
Show all investments...

Spark Crowdfunding
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotech startups

Ireland’s first & only Equity Crowdfunding platform.  Our mission is to provide private investors with access to new and exciting investment opportunities that previously would only have been available to Venture Capital and Private Equity funds.

Show more...

Investment focus

  • Industry: CRM, Software, Transportation
  • Stage:Seed, Equity Crowdfunding
  • Geography: Ireland

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Net Feasa — Net Feasa Ltd. is a technology company based in Ireland and Silicon Valley specializing in taking Yards, Ports, and Shipping Companies through Digital Transformation. For over 3 decades their management team has garnered expertise in; Communications, IoT, Cloud, Big Data, practical uses of Machine Learning, and Network Security. For 5 years we havebeen at the forefront of Industry 4.0 for the world's Yards, Ports, and Shipping Vessels. They have the scars, they have the war stories but most importantly they have learned in the field and they have built robust solutions that will meet their digital transformation requirements.
  • ClarityCX1 — ClarityCX1 develops tailored CRM solutions built on the Salesforce Lightning platform.
Show all investments...

Sol Global investments
VC Fund · Calgary, Alberta, Canada · 1 investments in Ireland Biotech startups

Tuned for performance. SOL Global Investments is a diversified private equity firm targeting best-in-class companies that operate in ultra-high growth industries. Our team has a proven track record of identifying pioneering businesses that are poised to disrupt the status quo and take

Show more...

Investment focus

  • Industry: Health Care, Cannabis, Cloud Computing
  • Stage:Corporate Round, Series A, Series B
  • Geography: United States, Canada, Ireland

Investor stats

  • Total investments: 11
  • Lead/follow: no public data

Portfolio highlights

  • Semasio — The Fyllo Compliance Cloud is a suite of software and services that enable organizations to navigate today’s ever-changing regulatory landscape, streamline compliance, and scale with speed. Mainstream brands also use the Fyllo Data Marketplace to target previously inaccessible cannabis and CBD consumers.The company was founded in 2019 and isheadquartered in Chicago, Illinois.
  • Cityrow Go — Cityrow Go is a rowing-based fitness app for smartphones or tablets. It offers rowing classes programmed to deliver an effective, efficient, and motivating workout to the at-home user. It was founded in 2013 and is based in New York, United States.
  • MCQ Markets — Start Investing in Investment-Grade Collector Cars with just $100. MCQ gives you access to invest in the same high-performance assets collectors and institutions are competing for.
Show all investments...

Medicxi
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Medicxi is an investment firm that focuses on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 53
  • Lead/follow: no public data

Portfolio highlights

  • Curevo — focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly
  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • Palladio Biosciences — Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics. Its products are designed for renal disease, kidney disease, and polycystic kidney disease.The company was founded in 2015 and headquartered inHorsham, Pennsylvania.
Show all investments...

Inventages Venture Capital Investment Inc.
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 37
  • Lead/follow: no public data

Portfolio highlights

  • Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
  • XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
  • Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
Show all investments...

MML Capital Partners
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.

Show more...

Investment focus

  • Industry: Manufacturing, Packaging Services, Information Technology
  • Stage:Private Equity, Series A
  • Geography: United Kingdom, France, United States

Investor stats

  • Total investments: 30
  • Lead/follow: no public data

Portfolio highlights

  • RAVL — Step into the future with RAVL and our revolutionary financial service technology solutions. We're not just building tech; we're crafting the future of financial services. Unleashing potential, one innovative solution at a time. Let's strategize, deliver, and repeat excellence together.
  • SCPACK GROUP — SCPACK GROUP is a packaging and containers manufacturing company for wine, cosmetics and more.
  • Ross-shire Engineering — Trusted water technology solutions and products for purifying drinking water, recycling effluent and cleaning water in industrial processes.
Show all investments...

DeepIE Ventures Management Co.
VC Fund · 1 investments in Ireland Biotech startups

DeepIE Ventures Management Co. operates as a venture capital firm.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Machinery Manufacturing
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
  • Synthara Technologies — Synthara is a Zurich-based artificial intelligence (AI) company that provides system-level solutions for businesses to enhance their products or services with smart features. The company portable and wearable gadgets such as virtual reality headsets, small wireless monitoring cameras, sensor networks, have limited smart features because computingpowerful algorithms cannot be run on them. Synthara IPs provide server-class performance with an extremely low energy requirement for neural networks (10 TOPs/Watt).
Show all investments...

Google Ventures
VC Fund · Mountain View, California, United States · 1 investments in Ireland Biotech startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 902
  • Lead/follow: no public data

Portfolio highlights

  • Instawork — Instawork connects local businesses with proven hourly workers for temp, temp-to-hire shift work.
  • SingleStore — SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured datainto a consolidated big data platform.
  • Resistant AI — Resistant AI provides fraud detection and prevention in automated document processing workflows, transaction monitoring, and identities analysis.
Show all investments...

Biotech VC funding in Ireland at a glance

Stats across 234 deals from 230 investors.

230
investors
in Ireland Biotech startups
234
deals
in Ireland Biotech startups
$4.7M
median round
in Ireland Biotech startups
52%
lead investors
lead at least one round
20%
Seed
most common funding stage

Access all 230 VC funds in Ireland Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 230 VC funds investing in Ireland Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists